Pacira Biosciences
PCRX
#5889
Rank
โ‚น67.80 B
Marketcap
โ‚น1,468
Share price
2.06%
Change (1 day)
-33.91%
Change (1 year)
Categories

Revenue for Pacira Biosciences (PCRX)

Revenue in 2024 (TTM): โ‚น57.49 Billion

According to Pacira Biosciences 's latest financial reports the company's current revenue (TTM ) is โ‚น58.32 Billion. In 2023 the company made a revenue of โ‚น56.19 Billion an increase over the revenue in the year 2022 that were of โ‚น55.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacira Biosciences from 2010 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น57.49 B2.33%
2023 โ‚น56.19 B1.83%
2022 โ‚น55.17 B36.9%
2021 โ‚น40.30 B28.28%
2020 โ‚น31.42 B4.66%
2019 โ‚น30.02 B27.31%
2018 โ‚น23.58 B28.86%
2017 โ‚น18.30 B-2.55%
2016 โ‚น18.78 B13.5%
2015 โ‚น16.54 B32.08%
2014 โ‚น12.52 B137.03%
2013 โ‚น5.28 B146.99%
2012 โ‚น2.13 B157.86%
2011 โ‚น0.82 B27.18%
2010 โ‚น0.65 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น6.36 B-89.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.48 B-85.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.92 B-98.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.52 B-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.90 B-88.17%๐Ÿ‡บ๐Ÿ‡ธ USA